These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 34287991)

  • 21. [Retrospective analysis of risk factors of liver cirrhosis combined with overt hepatic encephalopathy: a single -center case-control study].
    Fan YN; Ji TT; Liang RY; Yu YY; Xu JH
    Zhonghua Gan Zang Bing Za Zhi; 2021 Feb; 29(2):133-136. PubMed ID: 33685081
    [No Abstract]   [Full Text] [Related]  

  • 22. Total area of spontaneous portosystemic shunts independently predicts hepatic encephalopathy and mortality in liver cirrhosis.
    Praktiknjo M; Simón-Talero M; Römer J; Roccarina D; Martínez J; Lampichler K; Baiges A; Low G; Llop E; Maurer MH; Zipprich A; Triolo M; Maleux G; Fialla AD; Dam C; Vidal-González J; Majumdar A; Picón C; Toth D; Darnell A; Abraldes JG; López M; Jansen C; Chang J; Schierwagen R; Uschner F; Kukuk G; Meyer C; Thomas D; Wolter K; Strassburg CP; Laleman W; La Mura V; Ripoll C; Berzigotti A; Calleja JL; Tandon P; Hernandez-Gea V; Reiberger T; Albillos A; Tsochatzis EA; Krag A; Genescà J; Trebicka J;
    J Hepatol; 2020 Jun; 72(6):1140-1150. PubMed ID: 31954206
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence and risk factors of covert hepatic encephalopathy in cirrhotic patients: A multicenter study in China.
    Zeng X; Yin C; Sun CY; Lu CH; Zhao SS; Gao XH; Chen DF; Wen LZ; Lin S; Yang P; Zhang QH; Guan YJ; Zhang Y; Ren SQ; Cai DC; Zhang J; Li L; Chang CY; Zhou XL; Shi PM; Chen SY; Lin Y; Xie WF
    J Dig Dis; 2023 Feb; 24(2):122-132. PubMed ID: 37032126
    [TBL] [Abstract][Full Text] [Related]  

  • 24. QuickStroop Predicts Time to Development of Overt Hepatic Encephalopathy and Related Hospitalizations in Patients With Cirrhosis.
    Kanagalingam G; Park D; Badal BD; Fagan A; Thacker LR; Bajaj JS
    Clin Gastroenterol Hepatol; 2024 Apr; 22(4):899-901.e2. PubMed ID: 37797903
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early-Recurrent Overt Hepatic Encephalopathy Is Associated with Reduced Survival in Cirrhotic Patients after Transjugular Intrahepatic Portosystemic Shunt Creation.
    Zuo L; Lv Y; Wang Q; Yin Z; Wang Z; He C; Guo W; Niu J; Bai W; Li K; Yu T; Yuan X; Chen H; Liu H; Xia D; Wang E; Luo B; Li X; Yuan J; Han N; Nie Y; Fan D; Han G
    J Vasc Interv Radiol; 2019 Feb; 30(2):148-153.e2. PubMed ID: 30638778
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Validation of EncephalApp, Smartphone-Based Stroop Test, for the Diagnosis of Covert Hepatic Encephalopathy.
    Bajaj JS; Heuman DM; Sterling RK; Sanyal AJ; Siddiqui M; Matherly S; Luketic V; Stravitz RT; Fuchs M; Thacker LR; Gilles H; White MB; Unser A; Hovermale J; Gavis E; Noble NA; Wade JB
    Clin Gastroenterol Hepatol; 2015 Oct; 13(10):1828-1835.e1. PubMed ID: 24846278
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduced handgrip strength is predictive of poor survival among patients with liver cirrhosis: A sex-stratified analysis.
    Hanai T; Shiraki M; Imai K; Suetsugu A; Takai K; Moriwaki H; Shimizu M
    Hepatol Res; 2019 Dec; 49(12):1414-1426. PubMed ID: 31408558
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cognitive reserve is a determinant of health-related quality of life in patients with cirrhosis, independent of covert hepatic encephalopathy and model for end-stage liver disease score.
    Patel AV; Wade JB; Thacker LR; Sterling RK; Siddiqui MS; Stravitz RT; Sanyal AJ; Luketic V; Puri P; Fuchs M; Matherly S; White MB; Unser A; Heuman DM; Bajaj JS
    Clin Gastroenterol Hepatol; 2015 May; 13(5):987-91. PubMed ID: 25445772
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk factors for overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt creation in patients with liver cirrhosis.
    Tong H; Gan C; Wei B; Wang ZD; Li XD; Qian SJ; Huan H; Zhang LH; Yang Z; Chen YL; Gu YH; Chen LX; Yang YH; Wu H; Tang CW
    J Dig Dis; 2021 Jan; 22(1):31-40. PubMed ID: 33128287
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of Post-Traumatic Stress Disorder on Cognitive Function and Covert Hepatic Encephalopathy Diagnosis in Cirrhotic Veterans.
    Burroughs TK; Wade JB; Ellwood MS; Fagan A; Heuman DM; Fuchs M; Bajaj JS
    Dig Dis Sci; 2018 Feb; 63(2):481-485. PubMed ID: 29313245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Raised serum Interleukin-6 identifies patients with liver cirrhosis at high risk for overt hepatic encephalopathy.
    Labenz C; Toenges G; Huber Y; Nagel M; Marquardt JU; Schattenberg JM; Galle PR; Labenz J; Wörns MA
    Aliment Pharmacol Ther; 2019 Nov; 50(10):1112-1119. PubMed ID: 31583743
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Critical flicker frequency test predicts overt hepatic encephalopathy and survival in patients with liver cirrhosis.
    Barone M; Shahini E; Iannone A; Viggiani MT; Corvace V; Principi M; Di Leo A
    Dig Liver Dis; 2018 May; 50(5):496-500. PubMed ID: 29530628
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Advances in cirrhosis: Optimizing the management of hepatic encephalopathy.
    Liu A; Perumpail RB; Kumari R; Younossi ZM; Wong RJ; Ahmed A
    World J Hepatol; 2015 Dec; 7(29):2871-9. PubMed ID: 26692331
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prediction of overt hepatic encephalopathy by the continuous reaction time method and the portosystemic encephalopathy syndrome test in clinically mentally unimpaired patients with cirrhosis.
    Wernberg CW; Schaffalitzky de Muckadell OB; Vilstrup H; M Lauridsen M
    PLoS One; 2019; 14(12):e0226283. PubMed ID: 31830113
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic Implications of Minimal/Covert Hepatic Encephalopathy: Large-scale Validation Cohort Studies.
    Flud CR; Duarte-Rojo A
    J Clin Exp Hepatol; 2019; 9(1):112-116. PubMed ID: 30765944
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urinary metabolic profiling by
    McPhail MJ; Montagnese S; Villanova M; El Hadi H; Amodio P; Crossey MM; Williams R; Cox IJ; Taylor-Robinson SD
    Metab Brain Dis; 2017 Apr; 32(2):331-341. PubMed ID: 27638475
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overt hepatic encephalopathy impairs learning on the EncephalApp stroop which is reversible after liver transplantation.
    Acharya C; Wade JB; Fagan A; White M; Gavis E; Ganapathy D; Gilles H; Heuman DM; Bajaj JS
    Liver Transpl; 2017 Nov; 23(11):1396-1403. PubMed ID: 28885772
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation between interleukin-6 and ammonia in patients with overt hepatic encephalopathy due to cirrhosis.
    Luo M; Li L; Yang EN; Dai CY; Liang SR; Cao WK
    Clin Res Hepatol Gastroenterol; 2013 Sep; 37(4):384-90. PubMed ID: 23084463
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liver-Unrelated Comorbid Conditions Do Not Affect Cognitive Performance or Hepatic Encephalopathy Progression in Cirrhosis.
    Acharya C; Nadhem O; Shaw J; Hassouneh R; Fagan A; McGeorge S; Sterling RK; Puri P; Fuchs M; Luketic V; Sanyal AJ; Wade JB; Gilles HS; Heuman DM; Tinsley F; Matherly S; Lee H; Siddiqui MS; Thacker LR; Bajaj JS
    Am J Gastroenterol; 2021 Dec; 116(12):2385-2389. PubMed ID: 34140445
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deep stool microbiome analysis in cirrhosis reveals an association between short-chain fatty acids and hepatic encephalopathy.
    Bloom PP; Luévano JM; Miller KJ; Chung RT
    Ann Hepatol; 2021; 25():100333. PubMed ID: 33621653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.